Germany’s Cannabis Act (CanG) has not led to an increase in use among young people, according to new peer-reviewed research
Since April 2024, Berlin has cemented its place as the spiritual centre of the European cannabis industry. It is home
Ever since the Christian Democratic Union (CDU) became the largest party in Germany’s ruling coalition government in February 2025, the
As the European cannabis conference season gets started, industry experts, lawmakers, regulators and business owners are facing greater mainstream scrutiny
Next week will mark the second anniversary of the implementation of Germany’s landmark Cannabis Act (CanG), which came into force
Germany’s cannabis imports, according to the latest figures from BfArM, nearly tripled in size in 2025, cementing it beyond any
Germany’s imports for 2025 surpassed 200 tonnes for the first time, exceeding the country’s already revised import quota for the
As Trump’s rescheduling executive order dominated the cannabis industry’s attention over the holiday period, Germany’s controversial medical cannabis bill quietly
Germany’s telemedicine-fuelled expansion has driven the value of its medical cannabis market up by hundreds of millions of euros in
Since Germany’s Cannabis Act (CanG) came into force on 1 April 2024, much has changed regarding what was once the
This article is also available in German Germany’s new Federal Drug Commissioner, Prof Dr Hendrik Streeck (CDU), who in June
The blistering growth of Germany’s medical cannabis sector showed no signs of abating through the second quarter of 2025, with imports rising another 15% to hit new records.
You can also read this story in German, here. When the Cannabis Act came into force in Germany, the aim
Over the past few years, telemedicine has reshaped how patients access medical cannabis, launching a wave of digital clinics across
It was the goal of the previous German coalition government to protect the health of patients and consumers by legalising cannabis, ensuring better protection of minors and diversion from black market trade thanks to legal alternatives.
With the appointment of Prof. Dr. Hendrik Streeck as the new Federal Government Commissioner for Drugs, Burkhard Blienert had to say goodbye to this post,
seeing a supporter of legalisation replaced by a scientist who became well-known during the coronavirus pandemic take the helm in drug policy in Germany.
With Germany recently making some foundational changes to its medical cannabis framework, helping expand access significantly and driving a surge in patient numbers, we spoke to leading UK-based clinic Releaf to understand what structural, cultural, and clinical lessons the UK can learn from Germany’s success.
From Germany’s coalition agreement to the expansion of the Netherlands’ cannabis pilot and the Czech Republic’s medical cannabis market, industry news has managed to match the heady pace of the global news cycle.
We won’t spam you
